BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20483816)

  • 1. A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury.
    Baumgartner C; Lewis GD; Netzer M; Pfeifer B; Gerszten RE
    Bioinformatics; 2010 Jul; 26(14):1745-51. PubMed ID: 20483816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.
    Lewis GD; Wei R; Liu E; Yang E; Shi X; Martinovic M; Farrell L; Asnani A; Cyrille M; Ramanathan A; Shaham O; Berriz G; Lowry PA; Palacios IF; Taşan M; Roth FP; Min J; Baumgartner C; Keshishian H; Addona T; Mootha VK; Rosenzweig A; Carr SA; Fifer MA; Sabatine MS; Gerszten RE
    J Clin Invest; 2008 Oct; 118(10):3503-12. PubMed ID: 18769631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
    Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.
    Jacob J; Ngo D; Finkel N; Pitts R; Gleim S; Benson MD; Keyes MJ; Farrell LA; Morgan T; Jennings LL; Gerszten RE
    Circulation; 2018 Mar; 137(12):1270-1277. PubMed ID: 29222138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.
    Addona TA; Shi X; Keshishian H; Mani DR; Burgess M; Gillette MA; Clauser KR; Shen D; Lewis GD; Farrell LA; Fifer MA; Sabatine MS; Gerszten RE; Carr SA
    Nat Biotechnol; 2011 Jun; 29(7):635-43. PubMed ID: 21685905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.
    Ward-Caviness CK; Xu T; Aspelund T; Thorand B; Montrone C; Meisinger C; Dunger-Kaltenbach I; Zierer A; Yu Z; Helgadottir IR; Harris TB; Launer LJ; Ganna A; Lind L; Eiriksdottir G; Waldenberger M; Prehn C; Suhre K; Illig T; Adamski J; Ruepp A; Koenig W; Gudnason V; Emilsson V; Wang-Sattler R; Peters A
    Heart; 2017 Aug; 103(16):1278-1285. PubMed ID: 28255100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization.
    Puelacher C; Lurati Buse G; Seeberger D; Sazgary L; Marbot S; Lampart A; Espinola J; Kindler C; Hammerer A; Seeberger E; Strebel I; Wildi K; Twerenbold R; du Fay de Lavallaz J; Steiner L; Gurke L; Breidthardt T; Rentsch K; Buser A; Gualandro DM; Osswald S; Mueller C;
    Circulation; 2018 Mar; 137(12):1221-1232. PubMed ID: 29203498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials.
    Spitzer E; de Vries T; Cavalcante R; Tuinman M; Rademaker-Havinga T; Alkema M; Morel MA; Soliman OI; Onuma Y; van Es GA; Tijssen JGP; McFadden E; Serruys PW
    JACC Cardiovasc Interv; 2017 Apr; 10(7):658-666. PubMed ID: 28385402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention.
    Liu Y; Wang W; Song J; Zhang K; Wang K; Shao C; Li P; Xu B; Yang M; Chen J; Zheng J; Tang YD
    Int J Cardiol; 2021 Jun; 333():60-68. PubMed ID: 33744346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel network-based approach for discovering dynamic metabolic biomarkers in cardiovascular disease.
    Baumgartner C; Spath-Blass V; Niederkofler V; Bergmoser K; Langthaler S; Lassnig A; Rienmüller T; Baumgartner D; Asnani A; Gerszten RE
    PLoS One; 2018; 13(12):e0208953. PubMed ID: 30533038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry.
    Netzer M; Millonig G; Osl M; Pfeifer B; Praun S; Villinger J; Vogel W; Baumgartner C
    Bioinformatics; 2009 Apr; 25(7):941-7. PubMed ID: 19223453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new rule-based algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry.
    Osl M; Dreiseitl S; Pfeifer B; Weinberger K; Klocker H; Bartsch G; Schäfer G; Tilg B; Graber A; Baumgartner C
    Bioinformatics; 2008 Dec; 24(24):2908-14. PubMed ID: 18815183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart-Type Fatty Acid Binding Protein and Ischemia-Modified Albumin for Detection of Myocardial Infarction After Coronary Artery Bypass Graft Surgery.
    Thielmann M; Pasa S; Holst T; Wendt D; Dohle DS; Demircioglu E; Sharma V; Jakob H
    Ann Thorac Surg; 2017 Jul; 104(1):130-137. PubMed ID: 28189274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex quantitative imaging of human myocardial infarction by mass spectrometry-immunohistochemistry.
    Aljakna A; Lauer E; Lenglet S; Grabherr S; Fracasso T; Augsburger M; Sabatasso S; Thomas A
    Int J Legal Med; 2018 Nov; 132(6):1675-1684. PubMed ID: 29556718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late survival after perioperative myocardial infarction complicating vascular surgery.
    Yeager RA; Moneta GL; Edwards JM; Taylor LM; McConnell DB; Porter JM
    J Vasc Surg; 1994 Oct; 20(4):598-604; discussion 604-6. PubMed ID: 7933261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of high-resolution mass spectrometry-based data-mining tools in tandem to metabolite profiling of a triple drug combination in humans.
    Xing J; Zang M; Zhang H; Zhu M
    Anal Chim Acta; 2015 Oct; 897():34-44. PubMed ID: 26515003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.
    Keshishian H; Addona T; Burgess M; Mani DR; Shi X; Kuhn E; Sabatine MS; Gerszten RE; Carr SA
    Mol Cell Proteomics; 2009 Oct; 8(10):2339-49. PubMed ID: 19596694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying novel biomarkers through data mining-a realistic scenario?
    Griss J; Perez-Riverol Y; Hermjakob H; Vizcaíno JA
    Proteomics Clin Appl; 2015 Apr; 9(3-4):437-43. PubMed ID: 25347964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac troponin I and Q-wave perioperative myocardial infarction after coronary artery bypass surgery.
    Gensini GF; Fusi C; Conti AA; Calamai GC; Montesi GF; Galanti G; Noferi D; Carbonetto F; Palmarini MF; Abbate R; Vaccari M
    Crit Care Med; 1998 Dec; 26(12):1986-90. PubMed ID: 9875908
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.